Technical Papers and Posters

A Low Molecular Weight PSMA-Based Fluorescent Imaging Agent for Cancer.
Chen Y, Dhara S, Banerjee SR, Byun Y, Pullambhatla M, Mease RC, Pomper MG.
Biochem Biophys Res Commun. 2009 Oct 7.

New agents and techniques for imaging prostate cancer.
Zaheer A, Cho SY, Pomper MG.
J Nucl Med. 2009 Sep;50(9):1387-90. Epub 2009 Aug 18.

Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.
Chen Y, Foss CA, Byun Y, Nimmagadda S, Pullambhatla M, Fox JJ, Castanares M, Lupold SE, Babich JW, Mease RC, Pomper MG.
J Med Chem. 2008 Dec 25;51(24):7933-43.

Imaging virus-associated cancer.
Fu DX, Foss CA, Nimmagadda S, Ambinder RF, Pomper MG.
Curr Pharm Des. 2008;14(28):3048-65. Review.

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF.
Nat Med. 2008 Oct;14(10):1118-22. Epub 2008 Sep 7.

Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).
Banerjee SR, Foss CA, Castanares M, Mease RC, Byun Y, Fox JJ, Hilton J, Lupold SE, Kozikowski AP, Pomper MG.
J Med Chem. 2008 Aug 14;51(15):4504-17. Epub 2008 Jul 19.

Virus-associated tumor imaging by induction of viral gene expression.
Fu DX, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, Chong JM, Ambinder RF, Pomper MG.
Clin Cancer Res. 2007 Mar 1;13(5):1453-8.

Principio
15601 Crabbs Branch Way
Rockville, MD 20855
USA

301.526.5197 (phone)
301.738.0779 (fax)
info@principioinc.com